Janaína Esmeraldo Rocha

Janaína Esmeraldo Rocha

Auto-generated profile, based on publicly available information

Janaína Esmeraldo Rocha

Laboratory of Microbiology and Molecular Biology—LMBM, Regional University of Cariri—URCA, Crato 63105-000, CE, Brazil

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2019 in Foods
Verified
Journal Article
Open access
PDF file
BSBahare Salehi
Bahare Salehi
Zeliha SelamogluZeliha Selamoglu
Zeliha Selamoglu
BSBilge Sener
Bilge Sener
MKMehtap Kılıç
Mehtap Kılıç
AJArun Jugran
Arun Jugran
William C. ChoWilliam C. Cho
William C. Cho
The genus Berberis includes about 500 different species and commonly grown in Europe, the United States, South Asia, and some northern areas of Iran and Pakistan. Leaves and fruits can be prepared as food flavorings, juices, and teas. Phytochemical analysis of these species has reported alkaloids, tannins, phenolic compounds and oleanolic acid, among others. Moreover, p-cymene, limonene and ocimene as major compounds in essential oils were found by gas chromatography. Berberis is an important group of the plants having enormous potential in the food and pharmaceutical industry, since they possess several properties, including antioxidant, antimicrobial, anticancer activities. Here we would like to review the biological properties of the phytoconstituents of this genus. We emphasize the cultivation control in order to obtain the main bioactive compounds, the antioxidant and antimicrobial properties in order to apply them for food preservation and for treating several diseases, such as cancer, diabetes or Alzheimer. However, further study is needed to confirm the biological efficacy as well as, the toxicity.

10 December 2018 in Pathogens
Verified
Journal Article
Open access
PDF file
YFYara Faustino
Yara Faustino
MCMaria do Socorro Costa
Maria do Socorro Costa
Saulo TintinoSaulo Tintino
Saulo Tintino
JRJanaína Esmeraldo Rocha
Janaína Esmeraldo Rocha
FRFábio Fernandes Rodrigues
Fábio Fernandes Rodrigues
ESErlânio Oliveira De Sousa
Erlânio Oliveira De Sousa
Mauritia flexuosa (buriti) is a typical Brazilian palm tree found in swampy regions with many plant forms. The fruit has various purposes with the pulps to the seeds being used for ice creams, sweets, creams, jellies, liqueurs, and vitamin production. A physicochemical characterization of the fixed pulp oil and its antibacterial and aminoglycoside antibiotic modifying activity against Gram-positive and Gram-negative multiresistant bacterial strains were performed using broth microdilution assays. Physical properties, such as moisture, pH, acidity, peroxide index, relative density, and refractive index, indicated oil stability and chemical quality. In the GC/MS chemical composition analysis, a high content of unsaturated fatty acids (89.81%) in relation to saturated fatty acids (10.19%) was observed. Oleic acid (89.81%) was the main fatty acid identified. In the antibacterial test, the fixed oil obtained the Minimum Inhibitory Concentration (MIC) ≥ 1024 μg/mL for all standard and multiresistant bacterial strains. The synergic effect of fixed pulp oil combined was observed only in Staphylococcus aureus SA–10, with an MIC reduction of the gentamicin and amikacin by 40.00% and 60.55%, respectively. The data indicates the M. flexuosa fixed oil as a valuable source of oleic acid and modulator of aminoglycoside activity.

1 October 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
JXJayze da Cunha Xavier
Jayze da Cunha Xavier
FAFrancisco Wagner Almeida-Neto
Francisco Wagner Almeida-Neto
JRJanaína E. Rocha
Janaína E. Rocha
TFThiago Sampaio de Freitas
Thiago Sampaio de Freitas
PFPriscila R. Freitas
Priscila R. Freitas
ATAlexandre Teixeira
Alexandre Teixeira

16 September 2021 in Journal of Biomolecular Structure and Dynamics
Verified
Journal Article
Closed access
RORaíssa C. Oliveira
Raíssa C. Oliveira
PBPaulo N. Bandeira
Paulo N. Bandeira
TLTelma L. G. Lemos
Telma L. G. Lemos
Helcio Silva Dos SantosHelcio Silva Dos Santos
Helcio Silva Dos Santos
JSJackelyne R. Scherf
Jackelyne R. Scherf
ATAlexandre Teixeira
Alexandre Teixeira
The use of the bacterial efflux pump mechanism to reduce the concentrations of antibiotics in the intracellular to the extracellular region is one of the main mechanisms by which bacteria acquire resistance to antibiotics. The present study aims to evaluate the antibacterial activity of the α,β-amyrin mixture isolated from Protium heptaphyllum against the multidrug-resistant strains of Escherichia coli 06 and Staphylococcus aureus 10, and to verify the inhibition of the efflux resistance mechanisms against the strains of S. aureus 1199B and K2068, carrying the NorA and MepA efflux pumps, respectively. The α,β-amyrin did not show clinically relevant direct bacterial activity. However, the α,β-amyrin when associated with the gentamicin antibiotic presented synergistic effect against the multidrug-resistant bacterial strain of S. aureus 10. In strains with efflux pumps, α,β-amyrin was able to inhibit the action of the efflux protein NorA against Ethidium Bromide. However, this inhibitory effect was not observed in the MepA efflux pump. In addition, when evaluating the effect of standard efflux pump inhibitors, clorptomazine and CCCP, α,β-amyrin showed a decrease in MIC, demonstrating the presence of the efflux mechanism through synergism. Docking studies indicate that α, β-amyrin have a higher affinity energy to MepA, and NorA than ciprofloxacin and norfloxacin. Also, α, β-amyrin bind to the same region of the binding site as these antibiotics. It was concluded that the α, β-amyrin has the potential to increase antibacterial activity with the association of antibiotics, together with the ability to be a strong candidate for an efflux pump inhibitor. Communicated by Ramaswamy H. Sarma

3 May 2021 in Archives of Microbiology
Verified
Journal Article
Closed access
PDF file
RCRoger Henrique Sousa da Costa
Roger Henrique Sousa da Costa
JRJanaína Esmeraldo Rocha
Janaína Esmeraldo Rocha
TFThiago Sampaio de Freitas
Thiago Sampaio de Freitas
RPRaimundo Luiz Silva Pereira
Raimundo Luiz Silva Pereira
FJFrancisco Nascimento Pereira Junior
Francisco Nascimento Pereira Junior
Irwin Rose Alencar de MenezesIrwin Rose Alencar de Menezes
Irwin Rose Alencar de Menezes

4 December 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
JAJosé Weverton Almeida-Bezerra
José Weverton Almeida-Bezerra
Saulo Almeida MenezesSaulo Almeida Menezes
Saulo Almeida Menezes
JSJosé Thyálisson da Costa Silva
José Thyálisson da Costa Silva
SSSimone Galdino de Sousa
Simone Galdino de Sousa
DADaniel Sampaio Alves
Daniel Sampaio Alves
HCHenrique Coutinho
Henrique Coutinho
Background: Phytol is a diterpene from the long-chain unsaturated acyclic alcohols, known for its diverse biological effects, including antimicrobial and anti-inflammatory activities. Present in essential oils, phytol is a promising candidate for various applications in the pharmaceutical and biotechnological sectors. This study aimed to evaluate the in vitro antibacterial and drug-potentiating effects of phytol against multidrug-resistant bacteria and to evaluate its in silico properties: ADME and molecular docking. Methods: The in vitro antibacterial activity of phytol and the phytol combined with conventional drugs was evaluated by microdilution tests against standard and resistant bacterial strains. Finally, the SwissADME platform was employed to analyse the physicochemical and pharmacokinetic characteristics of phytol. Results: Phytol significantly reduced the Minimum Inhibitory Concentration (MIC) of norfloxacin and gentamicin required to inhibit multidrug-resistant strains of Escherichia coli and Staphylococcus aureus, respectively. Additionally, ADME analysis revealed that phytol exhibits low toxicity and favourable pharmacokinetic properties; in addition, it is revealed through molecular docking that phytol showed a relevant affinity with the proteins 6GJ1 and 5KDR, however, with values lower than the drugs gentamicin and ampicillin. Conclusions: Collectively, these findings suggest that phytol holds potential as an effective adjuvant in combating antimicrobial resistance.